In a combined network meta-analysis, infliximab and adalimumab had the greatest risk for serious infection in patients with plaque psoriasis.
A model that combines a host biomarker with a generative artificial intelligence (AI) analysis of electronic medical records ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback